Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7S3I

Ex4-D-Ala bound to the glucagon-like peptide-1 receptor/g protein complex (conformer 2)

7S3I の概要
エントリーDOI10.2210/pdb7s3i/pdb
関連するPDBエントリー7S1M
EMDBエントリー24825
分子名称Guanine nucleotide-binding protein G(s) subunit alpha isoforms short, Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2, ... (5 entities in total)
機能のキーワードglucagon, d-ala, exendin, glp-1, glp-1r, membrane protein
由来する生物種Homo sapiens (Human)
詳細
タンパク質・核酸の鎖数5
化学式量合計160122.49
構造登録者
Belousoff, M.J.,Piper, S.J.,Danev, R. (登録日: 2021-09-07, 公開日: 2022-01-05, 最終更新日: 2024-10-23)
主引用文献Cary, B.P.,Deganutti, G.,Zhao, P.,Truong, T.T.,Piper, S.J.,Liu, X.,Belousoff, M.J.,Danev, R.,Sexton, P.M.,Wootten, D.,Gellman, S.H.
Structural and functional diversity among agonist-bound states of the GLP-1 receptor.
Nat.Chem.Biol., 18:256-263, 2022
Cited by
PubMed Abstract: Recent advances in G-protein-coupled receptor (GPCR) structural elucidation have strengthened previous hypotheses that multidimensional signal propagation mediated by these receptors depends, in part, on their conformational mobility; however, the relationship between receptor function and static structures is inherently uncertain. Here, we examine the contribution of peptide agonist conformational plasticity to activation of the glucagon-like peptide 1 receptor (GLP-1R), an important clinical target. We use variants of the peptides GLP-1 and exendin-4 (Ex4) to explore the interplay between helical propensity near the agonist N terminus and the ability to bind to and activate the receptor. Cryo-EM analysis of a complex involving an Ex4 analog, the GLP-1R and G heterotrimer revealed two receptor conformers with distinct modes of peptide-receptor engagement. Our functional and structural data, along with molecular dynamics (MD) simulations, suggest that receptor conformational dynamics associated with flexibility of the peptide N-terminal activation domain may be a key determinant of agonist efficacy.
PubMed: 34937906
DOI: 10.1038/s41589-021-00945-w
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (2.51 Å)
構造検証レポート
Validation report summary of 7s3i
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon